Published on in Vol 3 , No 3 (2019) :Jul-Sep
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/13411, first published
.

Journals
- Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, Deshmukh B, Shinde V, Bishayee A, Deshmukh R. The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives. Molecules 2020;25(13):3011 View
- Sekandi J, Onuoha N, Buregyeya E, Zalwango S, Kaggwa P, Nakkonde D, Kakaire R, Atuyambe L, Whalen C, Dobbin K. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2021;10(1):e18029 View
- Donahue M, Eberly M, Rajnik M. Tele-TB: Using TeleMedicine to Increase Access to Directly Observed Therapy for Latent Tuberculosis Infection. Military Medicine 2021;186(Supplement_1):25 View
- Ragan E, Gill C, Banos M, Bouton T, Rooney J, Horsburgh C, Warren R, Myers B, Jacobson K. Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study. JMIR Research Protocols 2021;10(6):e24510 View
- Maraba N, Orrell C, Chetty-Makkan C, Velen K, Mukora R, Page-Shipp L, Naidoo P, Mbatha M, Fielding K, Charalambous S. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial. Trials 2021;22(1) View
- Zimmer A, Heitkamp P, Malar J, Dantas C, O'Brien K, Pandita A, Waite R. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2021;24:100248 View